BW430C

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BW430C, covering 2012-09-17 to 2012-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Evaluation of BW430C in Epilepsy [Phase 3]